Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s footer shows an updated site/application revision from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:08.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:31:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be a minor site maintenance update that does not alter the page content.
    Difference
    0.1%
    Check dated 2026-03-18T21:20:21.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible changes to study details, eligibility criteria, or results content.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:18.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Footer area now includes labels/links for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with a 'Helpful Links Provided by' note.
    Difference
    0.2%
    Check dated 2026-03-04T15:08:03.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Deleted sponsor attribution and navigation links (H. Lee Moffitt Cancer Center and Research Institute; Moffitt Cancer Center Clinical Trials website; Helpful Links) from the study page. This reduces visible context about the study's sponsor and related resources, affecting how users identify provenance and access additional information.
    Difference
    0.2%
    Check dated 2026-02-18T06:56:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.